Reckitt

Abbott and Reckitt Benckiser Clash in Court: $60M Verdict Over Enfamil Baby Formula

by

NORTH CHICAGO, ILLINOIS – Abbott Laboratories saw a decline in its stock price on Friday following a jury verdict in an Illinois state court. The jury ordered rival company Reckitt Benckiser’s Mead Johnson unit to pay $60 million over allegations that a premature child died after consuming the company’s Enfamil baby formula. This verdict represents the first trial outcome among the hundreds of lawsuits filed against both Reckitt Benckiser and Abbott, all claiming that their baby formulas caused a gastrointestinal disease called necrotizing enterocolitis (NEC) in children. Abbott’s stock dropped approximately 4% after the news, … Read more

Reckitt Benckiser Group Plc Faces Historic Blow as Enfamil Baby Formula Verdict Shakes Stock Market

by

(Chicago, Illinois) Consumer goods company Reckitt Benckiser Group Plc saw a drastic 15% drop in its stock following a jury’s decision to award an Illinois woman $60 million in damages. The verdict, which came in the first trial of its kind in the United States, stated that Reckitt Benckiser’s Enfamil baby formula was responsible for the death of the woman’s premature baby. This significant blow resulted in the company’s stock closing at its lowest level in a decade, erasing a staggering £5.4 billion ($6.9 billion) in market value. The ruling carries considerable implications for Reckitt … Read more

Consumer Giant Reckitt Plunges as Jury Awards $60 Million Verdict in Formula Saga

by

LONDON – Reckitt, a global consumer goods company headquartered in London, experienced a significant decline in its stock value following a jury verdict that ordered the company to pay $60 million. The verdict stemmed from a lawsuit over the formula of one of Reckitt’s products. The lawsuit alleged that Reckitt’s formula was misleadingly marketed as providing certain benefits that it didn’t actually deliver. The product in question, which was not specified, was said to have been advertised as having a specific effect, but the jury found that it did not live up to these claims. … Read more